CA Stock MarketDetailed Quotes

WLLW Willow Biosciences Inc

Watchlist
  • 0.120
  • +0.005+4.35%
15min DelayMarket Closed Jul 5 16:00 ET
15.27MMarket Cap-1500P/E (TTM)

Willow Biosciences Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
54.20%-1.75M
21.22%-10.92M
74.16%-1.07M
28.15%-2.35M
-8.10%-3.68M
-24.93%-3.82M
23.95%-13.86M
18.59%-4.13M
22.43%-3.27M
32.20%-3.41M
Net income from continuing operations
50.57%-2.36M
12.05%-13.03M
48.51%-2.42M
44.03%-2.23M
-14.38%-3.6M
-60.66%-4.77M
-141.27%-14.81M
9.41%-4.71M
-203.83%-3.99M
-148.31%-3.15M
Operating gains losses
-575.00%-135K
99.39%-23K
--0
96.71%-5K
100.12%2K
98.94%-20K
77.52%-3.76M
96.25%-45K
98.44%-152K
86.39%-1.68M
Depreciation and amortization
-22.12%352K
-30.80%1.83M
-22.75%377K
20.26%558K
-45.52%444K
-48.58%452K
-17.11%2.65M
-40.63%488K
-45.02%464K
5.03%815K
Asset impairment expenditure
--0
--19K
--0
--0
--0
--19K
--0
--0
--0
--0
Remuneration paid in stock
-70.08%158K
-71.25%420K
-59.20%82K
-194.79%-346K
-61.58%156K
7.98%528K
-14.21%1.46M
-61.93%201K
-26.41%365K
-22.96%406K
Deferred tax
----
---15K
----
----
----
----
--0
----
----
----
Other non cashItems
223.08%42K
-82.24%84K
828.57%65K
-109.92%-13K
-93.90%20K
85.71%13K
1,651.85%473K
-12.50%7K
1,771.43%131K
4,000.00%328K
Change In working capital
568.29%192K
-260.47%-207K
1,330.43%849K
-234.04%-314K
-456.35%-701K
-109.81%-41K
140.82%129K
-215.00%-69K
-129.65%-94K
75.91%-126K
-Change in receivables
110.59%18K
----
----
----
----
-2,733.33%-170K
----
----
----
----
-Change in inventory
-97.06%1K
----
----
----
----
88.89%34K
----
----
----
----
-Change in prepaid assets
-20.25%256K
----
----
----
----
9.93%321K
----
----
----
----
-Change in payables and accrued expense
29.20%-160K
----
----
----
----
-22,700.00%-226K
----
----
----
----
-Change in other working capital
--77K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
54.20%-1.75M
21.22%-10.92M
74.16%-1.07M
28.15%-2.35M
-8.10%-3.68M
-24.93%-3.82M
23.95%-13.86M
18.59%-4.13M
22.43%-3.27M
32.20%-3.41M
Investing cash flow
Cash flow from continuing investing activities
-96.12%135K
176.10%3.47M
100.17%6K
-110.45%-14K
99.89%-1K
1,159.76%3.48M
-171.98%-4.55M
-1,033.11%-3.46M
120.68%134K
-60.96%-903K
Capital expenditure reported
--0
9.24%-619K
-123.20%-58K
83.96%-30K
98.68%-7K
---524K
61.38%-682K
167.75%250K
66.67%-187K
-18.83%-530K
Net PPE purchase and sale
--135K
-94.31%7K
-91.25%7K
--0
----
--0
3.36%123K
--80K
--43K
----
Net investment purchase and sale
--0
199.50%4M
99.50%-20K
--21K
--1K
--4M
---4.02M
---4.02M
--0
--0
Net other investing changes
----
196.15%77K
----
-101.80%-5K
101.34%5K
----
196.30%26K
265.63%234K
419.54%278K
-59.40%-373K
Cash from discontinued investing activities
Investing cash flow
-96.12%135K
176.10%3.47M
100.17%6K
-110.45%-14K
99.89%-1K
1,159.76%3.48M
-171.98%-4.55M
-1,033.11%-3.46M
120.68%134K
-60.96%-903K
Financing cash flow
Cash flow from continuing financing activities
140.80%71K
56.02%-318K
238.34%267K
33.53%-115K
-67.23%-296K
3.33%-174K
-102.12%-723K
19.25%-193K
-8.81%-173K
-45.08%-177K
Net issuance payments of debt
-13.79%-198K
70.68%-212K
413.92%609K
-139.88%-415K
-33.33%-232K
4.40%-174K
-13.50%-723K
-18.29%-194K
-4.85%-173K
-10.13%-174K
Net common stock issuance
--270K
----
----
----
----
--0
----
----
----
----
Net other financing activities
---1K
---106K
---342K
--300K
-2,033.33%-64K
----
----
----
----
---3K
Cash from discontinued financing activities
Financing cash flow
140.80%71K
56.02%-318K
238.34%267K
33.53%-115K
-67.23%-296K
3.33%-174K
-102.12%-723K
19.25%-193K
-8.81%-173K
-45.08%-177K
Net cash flow
Beginning cash position
-71.43%3.15M
-63.45%11.01M
-80.03%3.68M
-70.70%6.47M
-60.28%10.47M
-63.45%11.01M
89.49%30.12M
-48.43%18.43M
-45.81%22.07M
-43.26%26.36M
Current changes in cash
-198.45%-1.54M
59.38%-7.77M
89.80%-793K
25.10%-2.48M
11.30%-3.98M
85.50%-517K
-234.54%-19.14M
-38.54%-7.78M
34.11%-3.31M
21.39%-4.49M
Effect of exchange rate changes
181.82%18K
-442.31%-89K
-111.80%-42K
97.92%-7K
-110.29%-21K
88.83%-22K
2,700.00%26K
17,700.00%356K
-1,785.00%-337K
1,669.23%204K
Cash adjustments other than cash changes
----
----
----
---301K
----
----
----
----
--0
----
End cash Position
-84.52%1.62M
-71.43%3.15M
-71.43%3.15M
-80.03%3.68M
-70.70%6.47M
-60.28%10.47M
-63.45%11.01M
-63.45%11.01M
-48.43%18.43M
-45.81%22.07M
Free cash from
59.73%-1.75M
20.66%-11.54M
71.00%-1.12M
31.17%-2.38M
6.27%-3.69M
-32.73%-4.34M
27.25%-14.54M
28.71%-3.88M
27.62%-3.46M
28.04%-3.94M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 54.20%-1.75M21.22%-10.92M74.16%-1.07M28.15%-2.35M-8.10%-3.68M-24.93%-3.82M23.95%-13.86M18.59%-4.13M22.43%-3.27M32.20%-3.41M
Net income from continuing operations 50.57%-2.36M12.05%-13.03M48.51%-2.42M44.03%-2.23M-14.38%-3.6M-60.66%-4.77M-141.27%-14.81M9.41%-4.71M-203.83%-3.99M-148.31%-3.15M
Operating gains losses -575.00%-135K99.39%-23K--096.71%-5K100.12%2K98.94%-20K77.52%-3.76M96.25%-45K98.44%-152K86.39%-1.68M
Depreciation and amortization -22.12%352K-30.80%1.83M-22.75%377K20.26%558K-45.52%444K-48.58%452K-17.11%2.65M-40.63%488K-45.02%464K5.03%815K
Asset impairment expenditure --0--19K--0--0--0--19K--0--0--0--0
Remuneration paid in stock -70.08%158K-71.25%420K-59.20%82K-194.79%-346K-61.58%156K7.98%528K-14.21%1.46M-61.93%201K-26.41%365K-22.96%406K
Deferred tax -------15K------------------0------------
Other non cashItems 223.08%42K-82.24%84K828.57%65K-109.92%-13K-93.90%20K85.71%13K1,651.85%473K-12.50%7K1,771.43%131K4,000.00%328K
Change In working capital 568.29%192K-260.47%-207K1,330.43%849K-234.04%-314K-456.35%-701K-109.81%-41K140.82%129K-215.00%-69K-129.65%-94K75.91%-126K
-Change in receivables 110.59%18K-----------------2,733.33%-170K----------------
-Change in inventory -97.06%1K----------------88.89%34K----------------
-Change in prepaid assets -20.25%256K----------------9.93%321K----------------
-Change in payables and accrued expense 29.20%-160K-----------------22,700.00%-226K----------------
-Change in other working capital --77K------------------------------------
Cash from discontinued investing activities
Operating cash flow 54.20%-1.75M21.22%-10.92M74.16%-1.07M28.15%-2.35M-8.10%-3.68M-24.93%-3.82M23.95%-13.86M18.59%-4.13M22.43%-3.27M32.20%-3.41M
Investing cash flow
Cash flow from continuing investing activities -96.12%135K176.10%3.47M100.17%6K-110.45%-14K99.89%-1K1,159.76%3.48M-171.98%-4.55M-1,033.11%-3.46M120.68%134K-60.96%-903K
Capital expenditure reported --09.24%-619K-123.20%-58K83.96%-30K98.68%-7K---524K61.38%-682K167.75%250K66.67%-187K-18.83%-530K
Net PPE purchase and sale --135K-94.31%7K-91.25%7K--0------03.36%123K--80K--43K----
Net investment purchase and sale --0199.50%4M99.50%-20K--21K--1K--4M---4.02M---4.02M--0--0
Net other investing changes ----196.15%77K-----101.80%-5K101.34%5K----196.30%26K265.63%234K419.54%278K-59.40%-373K
Cash from discontinued investing activities
Investing cash flow -96.12%135K176.10%3.47M100.17%6K-110.45%-14K99.89%-1K1,159.76%3.48M-171.98%-4.55M-1,033.11%-3.46M120.68%134K-60.96%-903K
Financing cash flow
Cash flow from continuing financing activities 140.80%71K56.02%-318K238.34%267K33.53%-115K-67.23%-296K3.33%-174K-102.12%-723K19.25%-193K-8.81%-173K-45.08%-177K
Net issuance payments of debt -13.79%-198K70.68%-212K413.92%609K-139.88%-415K-33.33%-232K4.40%-174K-13.50%-723K-18.29%-194K-4.85%-173K-10.13%-174K
Net common stock issuance --270K------------------0----------------
Net other financing activities ---1K---106K---342K--300K-2,033.33%-64K-------------------3K
Cash from discontinued financing activities
Financing cash flow 140.80%71K56.02%-318K238.34%267K33.53%-115K-67.23%-296K3.33%-174K-102.12%-723K19.25%-193K-8.81%-173K-45.08%-177K
Net cash flow
Beginning cash position -71.43%3.15M-63.45%11.01M-80.03%3.68M-70.70%6.47M-60.28%10.47M-63.45%11.01M89.49%30.12M-48.43%18.43M-45.81%22.07M-43.26%26.36M
Current changes in cash -198.45%-1.54M59.38%-7.77M89.80%-793K25.10%-2.48M11.30%-3.98M85.50%-517K-234.54%-19.14M-38.54%-7.78M34.11%-3.31M21.39%-4.49M
Effect of exchange rate changes 181.82%18K-442.31%-89K-111.80%-42K97.92%-7K-110.29%-21K88.83%-22K2,700.00%26K17,700.00%356K-1,785.00%-337K1,669.23%204K
Cash adjustments other than cash changes ---------------301K------------------0----
End cash Position -84.52%1.62M-71.43%3.15M-71.43%3.15M-80.03%3.68M-70.70%6.47M-60.28%10.47M-63.45%11.01M-63.45%11.01M-48.43%18.43M-45.81%22.07M
Free cash from 59.73%-1.75M20.66%-11.54M71.00%-1.12M31.17%-2.38M6.27%-3.69M-32.73%-4.34M27.25%-14.54M28.71%-3.88M27.62%-3.46M28.04%-3.94M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg